Aegis Therapeutics competitive analysis

Loading summary...

Explore Aegis Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 21, 2022Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease1

Latest PTAB cases involving Aegis Therapeutics

Discover the latest PTAB cases involving Aegis Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 4, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Aegis Therapeutics

IPR2021-01324Aug 12, 2021AMPHASTAR PHARMACEUTICALSAEGIS THERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Aegis Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AEGIS THERAPEUTICS - 1 - 1
AERA27 - - -
AMPHASTAR PHARMACEUTICALS - - 1 -